ArticleThrombosis journal2021

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis.

Kaidireyahan Wumaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.